explore -WSS

explore

author：comprehensive 2025-09-28 21:11:12 - browse：897

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

hotspot

WSS

Eating disorder hotline's move to chatbot carried cost for volunteers

Brazil's Jair Bolsonaro is barred from running for office until 2030

Ebola: Gilead Sciences antiviral shows promise as new treatment

Synthetic human embryos? Researchers say term is overblown

FDA advisers back CAR

Medical experts exlpore how to eliminate bias in clinical algorithms

entertainment

explore

knowledge

Medical leaders decry Supreme Court decision on affirmative action

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Guidelines to prevent youth baseball injuries need more muscle

Boston's new lab space is opening empty

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ukrainian soldiers say they owe lives to US

The high cost of giving birth even with insurance

ADA: All diabetes patients should be screened for liver condition

Medicare details structure of new drug price negotiation program

How many hemophilia patients actually want gene therapy?

focus

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

John Green on his newest strategy for fighting tuberculosis

Readout Newsletter: CAR

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

UnitedHealth wins $3.3 billion takeover of Amedisys

explore

focus

hotspot

hotspot